e-learning
resources
London 2016
Tuesday, 06.09.2016
Epidemiological and clinical data regarding the modern management of chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nasal nitric oxide (nNO) in paediatric primary ciliary dyskinesia (PCD) and in healthy children - On the lookout for optimal cut-off and reference range
Marcin Mikoś (Poznan, Poland), Marcin Mikos, Irena Wojsyk-Banaszak, Magdalena Roszak, Anna Breborowicz
Source:
International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Session:
Epidemiological and clinical data regarding the modern management of chronic lung diseases
Session type:
Poster Discussion
Number:
3559
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marcin Mikoś (Poznan, Poland), Marcin Mikos, Irena Wojsyk-Banaszak, Magdalena Roszak, Anna Breborowicz. Nasal nitric oxide (nNO) in paediatric primary ciliary dyskinesia (PCD) and in healthy children - On the lookout for optimal cut-off and reference range. Eur Respir J 2016; 48: Suppl. 60, 3559
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Relationship between age and online nasal nitric oxide measured using different techniques in children with suspected primary ciliary dyskinesia
Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Year: 2013
The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Inflammatory patterns in asthmatic children based on the measurement of alveolar nitric oxide
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Limitations of nasal nitric oxide as a screening method of primary ciliary dyskinesia in childhood
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016
Reference values for offline exhaled and nasal nitric oxide in healthy children
Source: Annual Congress 2013 –Assessing sleep disordered breathing and lung function in children
Year: 2013
Exhaled nitric oxide reference values in healthy Tunisian adults
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013
Gaz exchange, nasal nitric oxyde levels and lung function tests in children with primary ciliary dyskinesia
Source: International Congress 2015 – Respiratory physiology in children: technical and clinical aspects
Year: 2015
Alveolar nitric oxide and its role in asthma control assessment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
New portable nasal nitric oxide (nNO) analyser differentiates primary ciliary dyskinesia (PCD) from healthy individuals.
Source: International Congress 2017 – Primary ciliary dyskinesia and air pollution
Year: 2017
Nasal nitric oxide is low early in life: case study of two infants with primary ciliary dyskinesia
Source: Eur Respir J 2004; 24 : 881-883
Year: 2004
Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Effective patient selection for PCD diagnostics; the PICADAR score with nasal nitric oxide
Source: International Congress 2016 – Highlights in primary ciliary dyskinesia and asthma in childhood
Year: 2016
Nasal nitric oxide measurement and a score of key clinical features for the screening of primary ciliary dyskinesia in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Alveolar nitric oxide (C
alvNO
) measurement. Reference values in healthy people
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008
Nasal nitric oxide measurement in 39 children consecutively referred for primary ciliary dyskinesia work up
Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Year: 2007
Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Choice of nasal nitric oxide technique as first-line test for primary ciliary dyskinesia
Source: Eur Respir J 2011; 37: 559-565
Year: 2011
Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept